Atlas Trials

Beam Therapeutics Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Beam Therapeutics Inc.

RecordFirmDate
A Long-term Follow-up Study in Patients Who Received BEAM-101 (NCT07373639)Beam Therapeutics Inc.2025-12-15
This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects (NCT07304791)Beam Therapeutics Inc.2025-10-27
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa) (NCT06735755)Beam Therapeutics Inc.2024-12-06
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD) (NCT06389877)Beam Therapeutics Inc.2024-06-19
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) (NCT05885464)Beam Therapeutics Inc.2023-05-25
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease (NCT05456880)Beam Therapeutics Inc.2022-08-30

Track Beam Therapeutics Inc. automatically

Every clearance here is in the API, with alerts when new ones post.